- Home
- DAO vs GERN Comparison
DAO vs GERN Comparison
Compare DAO & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAO
- GERN
- Stock Information
- Founded
- DAO 2006
- GERN 1990
- Country
- DAO China
- GERN United States
- Employees
- DAO N/A
- GERN N/A
- Industry
- DAO Other Consumer Services
- GERN Biotechnology: Pharmaceutical Preparations
- Sector
- DAO Real Estate
- GERN Health Care
- Exchange
- DAO Nasdaq
- GERN Nasdaq
- Market Cap
- DAO 1.1B
- GERN 893.2M
- IPO Year
- DAO 2019
- GERN 1996
- Fundamental
- Price
- DAO $8.71
- GERN $1.40
- Analyst Decision
- DAO
- GERN Buy
- Analyst Count
- DAO 0
- GERN 8
- Target Price
- DAO N/A
- GERN $3.71
- AVG Volume (30 Days)
- DAO 114.7K
- GERN 8.0M
- Earning Date
- DAO 08-14-2025
- GERN 08-06-2025
- Dividend Yield
- DAO N/A
- GERN N/A
- EPS Growth
- DAO N/A
- GERN N/A
- EPS
- DAO 0.27
- GERN N/A
- Revenue
- DAO $785,636,394.00
- GERN $164,447,000.00
- Revenue This Year
- DAO $7.25
- GERN $175.15
- Revenue Next Year
- DAO $12.88
- GERN $56.61
- P/E Ratio
- DAO $31.18
- GERN N/A
- Revenue Growth
- DAO N/A
- GERN 11877.20
- 52 Week Low
- DAO $3.00
- GERN $1.09
- 52 Week High
- DAO $11.82
- GERN $4.83
- Technical
- Relative Strength Index (RSI)
- DAO 47.16
- GERN 51.31
- Support Level
- DAO $8.30
- GERN $1.40
- Resistance Level
- DAO $8.81
- GERN $1.52
- Average True Range (ATR)
- DAO 0.37
- GERN 0.07
- MACD
- DAO -0.07
- GERN -0.01
- Stochastic Oscillator
- DAO 24.24
- GERN 21.05
About DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.